Australia markets open in 4 hours 17 minutes
  • ALL ORDS

    7,281.10
    -50.50 (-0.69%)
     
  • AUD/USD

    0.7725
    -0.0119 (-1.51%)
     
  • ASX 200

    7,044.90
    -52.10 (-0.73%)
     
  • OIL

    65.79
    +0.51 (+0.78%)
     
  • GOLD

    1,819.70
    -16.40 (-0.89%)
     
  • BTC-AUD

    70,406.05
    -3,475.83 (-4.70%)
     
  • CMC Crypto 200

    1,459.18
    -104.65 (-6.69%)
     

$1.2 Billion Worldwide Diagnostic Specialty Enzymes Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

·3-min read

The "Diagnostic Specialty Enzymes - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Diagnostic Specialty Enzymes estimated at US$769 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027.

Protease, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$285.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Carbohydrases segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $227 Million, While China is Forecast to Grow at 5.7% CAGR

The Diagnostic Specialty Enzymes market in the U.S. is estimated at US$227 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$204.3 Million by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Polymerases and Nucleases Segment to Record 6.9% CAGR

In the global Polymerases and Nucleases segment, USA, Canada, Japan, China and Europe will drive the 7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$219.4 Million in the year 2020 will reach a projected size of US$351.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$133.8 Million by the year 2027.

Select Competitors (Total 41 Featured):

  • Advanced Enzymes Technologies Ltd.

  • Affymetrix, Inc.

  • Amano Enzymes Inc.

  • American Laboratories, Inc.

  • Amicogen, Inc.

  • BASF

  • BBI Solutions

  • Biocatalysts Ltd.

  • Codexis, Inc.

  • Dyadic International

  • F. Hoffmann-La Roche Ltd.

  • Life technologies

  • Micogen, Inc.

  • Nagase & Co. Ltd.

  • Novozymes A/S

  • Roche Holding Ag

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/oluan0

View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005761/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900